|
G
|
CSF3
|
colony stimulating factor 3
|
treatment
|
ISO
|
associated with Multiple Myeloma; associated with Graves Disease;
|
RGD |
PMID:8935143 PMID:15785251 |
RGD:11039034 RGD:11039041 |
NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108
|
|
G
|
IL1B
|
interleukin 1 beta
|
treatment
|
ISO
|
associated with Glioblastoma;
|
RGD |
PMID:1331350 |
RGD:10450883 |
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
|
|
G
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
ISO
|
associated with Leukemia;protein:decreased expression:serum:
|
RGD |
PMID:8698137 |
RGD:11528539 |
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
|
|
|
G
|
ACE
|
angiotensin I converting enzyme
|
severity
|
ISO
|
DNA:deletion:intron:IVS16+1464-1751del (human) associated with acute leukemia;DNA:insertion/deletion:intron 16:
|
RGD |
PMID:15806540 PMID:24819208 |
RGD:11038917 RGD:11530041 |
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
|
|
G
|
GSTP1
|
glutathione S-transferase pi 1
|
susceptibility
|
ISO
|
DNA:polymorphism: : rs1695(human)
|
RGD |
PMID:25008867 |
RGD:10755412 |
NCBI chr18:49,905,161...49,908,182
Ensembl chr18:49,905,161...49,908,182
|
|
G
|
ITPA
|
inosine triphosphatase
|
|
ISO
|
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNP: :rs41320251 (human)
|
RGD |
PMID:18685564 |
RGD:10766478 |
NCBI chr24:18,070,980...18,081,815
Ensembl chr24:18,064,983...18,082,163
|
|
G
|
LOC478984
|
low affinity immunoglobulin gamma Fc region receptor III
|
treatment
|
ISO
|
associated with Lymphoma, Large B-Cell, Diffuse;DNA:SNP: :rs396991 (human)
|
RGD |
PMID:27282998 |
RGD:11344967 |
NCBI chr38:21,054,870...21,060,948
|
|
G
|
MBL1
|
mannose binding lectin 1
|
susceptibility disease progression
|
ISO
|
associated with Neoplasms;DNA:SNP,haplotyep:promoter: associated with leukemia; associated with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphisms:exon:
|
RGD |
PMID:20930093 PMID:24453114 PMID:24819208 |
RGD:11530041 RGD:11530043 RGD:11530056 |
NCBI chr 4:29,419,886...29,424,377
|
|
G
|
MDM2
|
MDM2 proto-oncogene
|
susceptibility
|
ISO
|
associated with Breast Neoplasms;DNA:SNP:cds:309T>G(rs2279744)(human)
|
RGD |
PMID:21706156 |
RGD:11073725 |
NCBI chr10:10,936,288...10,963,118
Ensembl chr10:10,893,719...10,962,596
|
|
G
|
TP53
|
tumor protein p53
|
susceptibility
|
ISO
|
associated with Breast Neoplasms;DNA:SNP:cds: p.R72P(rs1042522)(human)
|
RGD |
PMID:21706156 |
RGD:11073725 |
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
|
|
|
G
|
ABCB1
|
ATP binding cassette subfamily B member 1
|
susceptibility
|
ISO
|
associated with Carcinoma, Non-Small-Cell Lung;DNA:SNP: :2677G>T(human) associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNPs:rs1045642,rs1128503(human) Breast Neoplasms;DNA:SNP: :3435 C>T(human)
|
RGD |
PMID:17534875 PMID:22271208 PMID:25007187 |
RGD:11080964 RGD:11080979 RGD:11081001 |
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
|
|
G
|
ABCC2
|
ATP binding cassette subfamily C member 2
|
susceptibility no_association
|
ISO
|
associated with neoplasm;DNA:SNP:rs12762549(human)
|
RGD |
PMID:18294295 PMID:23188068 |
RGD:11080980 RGD:11080999 |
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
|
|
G
|
CSF3
|
colony stimulating factor 3
|
treatment
|
ISO
|
associated with Hepatitis C, Chronic; associated with Leukemia, Hairy Cell;
|
RGD |
PMID:2461131 PMID:17660602 |
RGD:11039035 RGD:11039036 |
NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108
|
|
G
|
DLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
ISO
|
|
RGD |
PMID:27400856 |
RGD:14928329 |
NCBI chr12:2,305,307...2,307,711
|
|
G
|
DPYD
|
dihydropyrimidine dehydrogenase
|
treatment no_association
|
ISO
|
associated with Neoplasms;DNA:splice-site mutation:intron:IVS14+1G>A (human) associated with Colorectal Neoplasms;DNA:SNPs: :rs1801159 (1896T>C), rs17376848 (human) DNA:splice-site mutation, missense mutations: :multiple associated with Neoplasms;DNA:missense mutations: :multiple associated with Neoplasms;DNA:missense mutation: :p.M166V (496A>G) (human)
|
RGD |
PMID:11156223 PMID:12209976 PMID:19473056 PMID:23942539 |
RGD:11098817 RGD:11251736 RGD:11251737 RGD:11251738 |
NCBI chr 6:51,789,786...52,564,802
Ensembl chr 6:51,814,573...52,580,923
|
|
G
|
ERCC1
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
treatment
|
ISO
|
associated with Colorectal Neoplasms;DNA:SNP
|
RGD |
PMID:23543295 |
RGD:11340199 |
NCBI chr 1:110,130,353...110,146,660
Ensembl chr 1:110,130,481...110,146,602
|
|
G
|
ERCC2
|
ERCC excision repair 2, TFIIH core complex helicase subunit
|
treatment
|
ISO
|
associated with Urinary Bladder Neoplasms;DNA:SNP: :p.K751Q (rs13181) (human)
|
RGD |
PMID:21047201 |
RGD:11098572 |
NCBI chr 1:110,173,781...110,191,612
Ensembl chr 1:110,173,715...110,190,125
|
|
G
|
ERCC6
|
ERCC excision repair 6, chromatin remodeling factor
|
treatment
|
ISO
|
associated with lung non-small cell carcinoma;DNA:SNP:intron: (rs4253212) (human)
|
RGD |
PMID:28924235 |
RGD:153323316 |
NCBI chr28:1,358,383...1,432,276
Ensembl chr28:1,361,107...1,427,162
|
|
G
|
GSTP1
|
glutathione S-transferase pi 1
|
susceptibility
|
ISO
|
DNA:SNP:cds:p.I105V (rs1695) (human)
|
RGD |
PMID:23812950 |
RGD:10755330 |
NCBI chr18:49,905,161...49,908,182
Ensembl chr18:49,905,161...49,908,182
|
|
G
|
IL1A
|
interleukin 1 alpha
|
treatment
|
ISO
|
associated with Carcinoma, Non-Small-Cell Lung
|
RGD |
PMID:7666093 |
RGD:11051963 |
NCBI chr17:36,969,581...36,979,445
Ensembl chr17:36,970,573...36,979,435
|
|
G
|
LOC478984
|
low affinity immunoglobulin gamma Fc region receptor III
|
|
ISO
|
associated with Lymphoma, Large B-Cell, Diffuse;DNA:polymorphism: :p.V158F (human) associated with Non-Hodgkin lymphoma;DNA:polymorphism: :p.V158F (human) associated with Lymphoma, B-Cell;DNA:polymorphism: :p.V158F (human)
|
RGD |
PMID:19933905 PMID:20730791 PMID:21883784 |
RGD:11344964 RGD:11344973 RGD:11352256 |
NCBI chr38:21,054,870...21,060,948
|
|
G
|
MDM2
|
MDM2 proto-oncogene
|
susceptibility
|
ISO
|
associated with Small Cell Lung Carcinoma;DNA:SNP::rs2279744(human)
|
RGD |
PMID:24732641 |
RGD:11073715 |
NCBI chr10:10,936,288...10,963,118
Ensembl chr10:10,893,719...10,962,596
|
|
G
|
POLD1
|
DNA polymerase delta 1, catalytic subunit
|
treatment
|
ISO
|
associated with lung non-small cell carcinoma; DNA:SNPs:exon, introns: (rs1726801, rs1673041, rs3219341) (human)
|
RGD |
PMID:28924235 |
RGD:153323316 |
NCBI chr 1:106,302,583...106,331,353
Ensembl chr 1:106,302,574...106,331,385
|
|
G
|
SLCO1B2
|
solute carrier organic anion transporter family member 1B2
|
no_association susceptibility
|
ISO
|
associated with neoplasm;DNA:SNP: rs11045585(human) associated with neoplasm;DNA:SNP:rs11045585(human)
|
RGD |
PMID:18294295 PMID:23188068 |
RGD:11080980 RGD:11080999 |
NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
|
|
G
|
SOD2
|
superoxide dismutase 2
|
susceptibility
|
ISO
|
associated with female breast cancer;DNA:missense mutation:cds:p.V16A (rs4880) (human)
|
RGD |
PMID:20309628 |
RGD:11035278 |
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
|
|
G
|
TP53
|
tumor protein p53
|
susceptibility
|
ISO
|
associated with Small Cell Lung Carcinoma;DNA:SNP:: rs1042522(human)
|
RGD |
PMID:24732641 |
RGD:11073715 |
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
|
|